This feature is often associated with translocation of TRIM genes and creation of oncogenic fusion products, as in the case of TRIM19/PML, TRIM27/RFP and TRIM24/TIF1α, but they can influence cancer progression also per se [33]. The gene discussed is TRAT1; the disease is cancer.